GSD Devonian Health Group Inc.

4.719USD6.750 CAD · TSXV+7.14%Mkt Cap: 13.12M USDP/E: —

Devonian Health Group Inc. operates as a clinical stage biopharmaceutical corporation with novel therapeutic approaches targeting unmet medical needs in Canada and Internationally. It engages in the development of botani…

Institutional holders1 on file

Key Statistics

Company
Market Cap13.12M USD
Enterprise Value12.72M USD
Revenue (TTM)2.09M USD
Gross Profit5.98M USD
Net Income (TTM)-4.20M USD
Revenue/Share0.78 USD
Last Price4.719 USD
Fiscal Year EndJul 2025
MR QuarterApr 2026
Employees8
CountryCA
SectorHealthcare
IndustryBiotechnology
ISINCA2518348834
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-3.07
EV/Revenue6.07
P/S6.27
P/B2.69
EPS (TTM)-1.49 USD
EPS (Forward)—
52W Range
0.132844% of range10.49
52W High10.49 USD
52W Low0.1328 USD
Profitability
Gross Margin36.28%
Oper. Margin-206.69%
EBITDA Margin-197.67%
Profit Margin-25.49%
ROE-65.80%
ROA-37.98%
ROIC-33.82%
ROCE-8.37%
Growth
Revenue Growth-97.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF-872.25K USD
CapEx (TTM)12.13K USD
FCF Margin-319.51%
FCF Yield-50.98%
Net Debt-405.02K USD
Net Debt/EBITDA0.10
Net Debt/FCF—
Balance Sheet
Debt/Equity0.01
Current Ratio1.00
Quick Ratio0.78
Book Value/Sh1.75 USD
Cash/Share0.18 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay DateMay 19, 2017
Splits
Last Split1:60
Split DateJan 22, 2026
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.2.78M
Float2.11M
Insiders12.04%
Institutions7.54%
Short Interest
Short Ratio0.4d
Short % Out.0.04%
Shares Short1.09K
Short (prev mo.)570
Technical
SMA 505.340 (-11.6%)
SMA 2006.897 (-31.6%)
Beta1.00
S&P 52W Chg12.00%
Avg Vol (30d)2.23K
Avg Vol (10d)100
Technical Indicators
RSI (14)44.4
MACD-0.4092
MACD Signal-0.4122
MACD Hist.+0.0030
BB Upper5.475 USD
BB Middle4.870 USD
BB Lower4.265 USD
BB Width24.84%
ATR (14)0.2382 USD
Vol Ratio (20d)1.03x

About Devonian Health Group (CVE: GSD)

›

Devonian Health Group (CVE: GSD) is listed on the TSX Venture Exchange, where its shares trade in CAD. It belongs to the Biotechnology industry, part of the Healthcare sector, and reports about 8 employees.

The shares were at 6.750 CAD on 19 November 2026, down 55.0% over 52 weeks. Its 52-week range is 0.1900 CAD to 15.00 CAD: the price is 55.0% below the high and 3452.6% above the low.

Its market capitalisation is 18.77M CAD.

Devonian Health Group reports return on equity of -65.8%, an operating margin of -206.7% and revenue down 97.6% year over year.

It holds more cash than debt, a net cash position of 579.39K CAD. Its Piotroski F-score is 5 out of 9, an average reading of its financial health. The next earnings report is expected on 26 November 2026.